Getting Ready
In the next week or two, a scientific paper will be published on line (and in print soon after) in a leading cardiology journal. This journal is the preeminent cardiology journal, and I am very proud that it's the journal where the results of my work with talented colleagues over the last 2.5 years will be published. The journal is so impressed by the importance of this research that there will be an editorial about it.
Now I am not permitted to say where this article will be published or reveal the contents, but if you were to look back over the entries in this blog since November, you will probably be able to guess. The research indicates that a drug that is commonly used appears likely to have some risk; risk previously not appreciated and risk that is quite relevant.
Last week at the American College of Cardiology meeting, a colleague told me that the manufacturer of this medicine is preparing a statement/press release in response to this paper. I'm not sure what it may say, but I am confident that if I focus the discussions on the data, all will work out smoothly.
I'm ready for anything. After all, what could a multibillion dollar company possibly do to me that would be damaging? Especially when they have projected this medicine to reach one billion dollars in annual sales?
The data will be the story. That's where the focus must remain.
<< Home